Drug & intervention

allopurinol

RxCUI 519

Clinical trials19
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Allopurinol

Allopurinol is a medication used to decrease high blood uric acid levels. It is specifically used to prevent gout, prevent specific types of kidney stones and for the high uric acid levels that can occur with chemotherapy. It is taken orally (by mouth) or intravenously (injected into a vein). Common side effects when used orally include itchiness and rash. Common side effects when used by injection include vomiting and kidney problems. While not recommended historically, starting allopurinol during an attack of gout appears to be safe. In those already on the medication, it should be continued even during an acute gout attack. While use during pregnancy does not appear to result in harm, this use has not been well studied. Allopurinol is in the xanthine oxidase inhibitor family of medications. Allopurinol was approved for medical use in the United States in 1966. It is on the World Health Organization's List of Essential Medicines. Allopurinol is available as a generic medication. In 2023, it was the 45th most commonly prescribed medication in the United States, with more than 14 million prescriptions.

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

19 shown
ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICSNCT07177898 · 2023-05-14
COMPLETED
Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)NCT05049863 · 2023-02-27
TERMINATED
Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery DiseaseNCT03700645 · 2018-12-01
UNKNOWN
Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric AcidNCT03648996 · 2018-11-01
COMPLETED
Allopurinol and Endothelial Function in Diabetic CAD PatientsNCT03385135 · 2017-12-01
UNKNOWN
PERL Continuous Glucose Monitoring (CGM) StudyNCT03334318 · 2017-10-01
COMPLETED
The Effect of Antioxidants on Skin Blood Flow During Local HeatingNCT03680638 · 2016-09-07
COMPLETED
Microalbuminuria and Allopurinol in Type 1 DiabetesNCT02829177 · 2014-09-01
COMPLETED
Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?NCT02237339 · 2014-09-01
COMPLETED
Center of Research Translation (CORT) Project 2NCT02038179 · 2014-07-01
COMPLETED
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 DiabetesNCT02017171 · 2014-02-01
COMPLETED
Study of Cardiovascular Disease and Obstructive Sleep ApneaNCT01637623 · 2012-06-01
COMPLETED
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel FunctionNCT01320722 · 2011-03-01
COMPLETED
Hyperuricemia on Hypertension and Metabolic SyndromeNCT01157936 · 2010-07-01
COMPLETED
Primary Prevention of Hypertension in Obese AdolescentsNCT00288158 · 2008-09-01
COMPLETED
Allopurinol for Renal Transplant Associated Hypertension in ChildrenNCT00288171 · 2006-02-01
WITHDRAWN
Uric Acid and Hypertension in African AmericansNCT00241839 · 2005-08-01
COMPLETED
Impact of Diabetes on Left Ventricular RemodelingNCT01052272 · 2005-07-01
COMPLETED
Uric Acid in Essential Hypertension in ChildrenNCT00288184 · 2004-09-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.